The Clinical Benefits of Tria

What makes Tria unlike any other?

View the on-demand webinar presented by Ben H. Chew, MD, and Daniel Perez Fentes, MD, at the Technology and Training in Endourology 2021 International Meeting. Learn about stent encrustation, discoloration and patient tolerability, as well as Tria™ Ureteral Stent innovations.

Stent Encrustation, Discoloration and Patient Tolerability

When it comes to ureteral stents, urine calcium (Ca) and magnesium (Mg) salt deposits can contribute to stent complications such as encrustation.^1,2 The cause and rate of encrustation is multifactorial and can include factors such as body chemistry and medical condition of the patient, stent indwell time, and surface material or properties of the stent.^2-4 The Tria stent may help control the accumulation of Mg and Ca salts.^5-6

Furthermore the Tria Stent is designed to be stiffer during placement to navigate patient anatomy while softening by over 40% at body temperature, which may promote greater patient tolerability.⁷